MedTrace Logo

Effect of Vitamin D3 Supplementation in Pregnancy on Risk of Pre-eclampsia

NCT03101150 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 179

Last updated 2018-11-02

Study results available
· View outcomes & findings →

Summary

Vitamin D deficient pregnant ladies were selected and randomized into 2 groups for routine daily dose of multivitamin (400IU vitamin D3) versus maximum safest treatment daily dose (4000IU vitamin D3). Participants were assessed and compared for number of pre-eclampsia cases.

Conditions

  • Vitamin D Deficiency
  • Pre-Eclampsia

Interventions

DRUG

400 IU Vitamin D3

Antenatal multivitamin

DRUG

4000 IU Vitamin D3

4000 IU Vitamin D3 (cholecalciferol) daily = 40 drops daily

Sponsors & Collaborators

  • King Fahad Medical City

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-01
Primary Completion
2014-10-31
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03101150 on ClinicalTrials.gov